Abstract
BackgroundA spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto (R) Plus) was developed for the treatment of ne......
小提示:本篇文献需要登录阅读全文,点击跳转登录